Fractyl Health, Inc., a leading metabolic therapeutics company, announced that CEO Dr. Harith Rajagopalan will be participating in a fireside chat at the BofA Securities 2024 Health Care Conference on Wednesday, May 15, 2024, at 4:20 p.m. PDT (7:20 p.m. EDT). Interested individuals can sign up in advance for the webcast on the company’s website.
Fractyl Health is dedicated to developing innovative treatments for metabolic diseases such as obesity and type 2 diabetes (T2D). Despite significant advances in treatment options, these conditions continue to be major causes of morbidity and mortality in modern times. The company’s mission is to shift the focus of metabolic disease treatment from managing symptoms to providing long-lasting therapies that target the root causes of the diseases at an organ level. Fractyl Health is headquartered in Burlington, MA.
For more information about Fractyl Health and their work towards treating metabolic diseases, visit their website at www.fractyl.com or follow them on Twitter at https://twitter.com/FractylHealth. Investors, media inquiries, and corporate communication contact information can also be found on their website.
